Efficacy of Oral BG-12 (Dimethyl Fumarate) in Patients Newly Diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Analysis of DEFINE and CONFIRM

被引：0
|
作者：
Gold, R. [1 ]
Giovannoni, G. [2 ]
Phillips, J. T. [3 ]
Fox, R. J. [4 ]
Rana, J. [5 ]
Zhang, A. [5 ]
Meltzer, L. [5 ]
Kurukulasuriya, N. C. [5 ]
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[5] Biogen Idec Inc, Weston, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-65
引用
收藏
页码：931 / 932
页数：2
相关论文
共 50 条
  • [41] Lymphocyte count reductions in relapsing remitting multiple sclerosis (RRMS) patients treated with oral BG-12 (dimethyl fumarate): integrated analysis of the placebo-controlled studies
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Raghupathi, K.
    Yuan, H.
    O'Gorman, J.
    Novas, M.
    Viglietta, V.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 469 - 469
  • [42] Clinical efficacy of delayed-release dimethyl fumarate in Asian patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hochman, S.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E307
  • [43] Clinical efficacy of delayed-release dimethyl fumarate in Hispanic patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hernandez, L.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E306
  • [44] Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
    Lilyana Amezcua
    Yang Mao-Draayer
    Wendy S. Vargas
    Rebecca Farber
    Sara Schaefer
    Filipe Branco
    Sarah M. England
    Nicholas Belviso
    James B. Lewin
    Jason P. Mendoza
    Sai L. Shankar
    Neurology and Therapy, 2023, 12 : 883 - 897
  • [45] Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
    Amezcua, Lilyana
    Mao-Draayer, Yang S.
    Vargas, Wendy
    Farber, Rebecca
    Schaefer, Sara
    Branco, Filipe M.
    England, Sarah
    Belviso, Nicholas B.
    Lewin, James P.
    Mendoza, Jason L.
    Shankar, Sai
    ENDORSE Study Investigators
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 883 - 897
  • [46] Effects of BG-12 on magnetic resonance imaging outcomes in relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Miller, D. H.
    Gold, R.
    Fox, R. J.
    MacManus, D.
    Yousry, T.
    Bar-Or, A.
    Zhang, R.
    Viglietta, V.
    Stephan, M.
    Dawson, K. T.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 418 - 418
  • [47] Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
    Kita, Mariko
    Fox, Robert J.
    Phillips, J. Theodore
    Hutchinson, Michael
    Havrdova, Eva
    Sarda, Sujata P.
    Agarwal, Sonalee
    Kong, Jessica
    Zhang, Annie
    Viglietta, Vissia
    Sheikh, Sarah I.
    Seidman, Emily
    Dawson, Katherine T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (02) : 253 - 257
  • [48] Three-year follow-up of oral BG-12 (dimethyl fumarate) treatment in relapsing remitting multiple sclerosis (RRMS): integrated magnetic resonance imaging (MRI) outcomes from DEFINE, CONFIRM, and ENDORSE
    Miller, D. H.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    MacManus, D.
    Yousry, T.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Dawson, K. T.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 461 - 462
  • [49] Longer-Term Follow-Up of the Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: Integrated Analysis of DEFINE, CONFIRM and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert
    Zhang, Annie
    Taylor, Catherine
    Marantz, Jing
    NEUROLOGY, 2016, 86
  • [50] Seven-year follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Xiao, J.
    Taylor, C.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 296 - 297
12345